Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00108628 |
|
Recruitment Status :
Completed
First Posted : April 18, 2005
Results First Posted : February 18, 2015
Last Update Posted : February 18, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Post-traumatic Stress Disorder | Behavioral: Imagery Rehearsal Behavioral: Sleep and Nightmare Management | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 134 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | 7857 Cognitive - Behavioral Treatments for PTSD Sleep Disturbance |
| Study Start Date : | April 2004 |
| Actual Primary Completion Date : | September 2008 |
| Actual Study Completion Date : | July 2013 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Arm 1
Imagery Rehearsal Therapy
|
Behavioral: Imagery Rehearsal
IR is a manual-based CBT predicated on the idea that waking mental activity influences nighttime dreams. Veterans examine the content of a recurrent nightmare, use imagery to alter disturbing aspects of the nightmare to promote mastery and control, and rehearse the new dream nightly, before bedtime. |
|
Active Comparator: Arm 2
Sleep and Nightmare Management
|
Behavioral: Sleep and Nightmare Management
This comparison condition involved psychoeducation about PTSD, sleep and nightmares, progressive muscle relaxation and standard CBT for insomnia. This latter part included education about sleep hygiene (e.g., avoidance of caffeine and alcohol close to bedtime, benefit of regular bed time routines), stimulus control and sleep restriction (i.e., reestablishing a conditioned association between the bed/bedroom and sleep by reducing time spent tossing and turning in bed). Therapists worked with patients to identify problem areas in their sleep habits and to problem-solve about possible treatment targets |
- Weekly Number of Nightmares [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]
- Weekly Nights With a Nightmare [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]
- Pittsburgh Sleep Quality Index [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]Total scores range from 0 to 21, with higher values indicating poorer sleep quality. A score greater than 5 distinguishes between poor and good sleepers.
- Pittsburgh Sleep Quality Index - Addendum [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]The PSQI-A is a measure of PTSD-related sleep and dream disturbances. Scores can range from 0 to 21, with higher scores reflecting greater sleep problems.
- Nightmare Effects Survey [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]This self-report questionnaire assesses psychosocial impairment attributed to nightmares. Eleven self-report questions are rated on a scale of zero to four. The individual scores are summed to produce a total score ranging from 0 to 44 (reported in the Table). Higher scores reflect greater impairment.
- PTSD Military Checklist [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]Seventeen items indicating the 17 DSM-IV criteria for PTSD are rated on a 5-point scale, from 1 to 5. Scores range from 17 to 85, with a higher score indicating greater symptom severity.
- Beck Depression Inventory [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]Twenty-one items are rated on a 4-point scale. Total scores range from zero to 63, with higher scores indicating more severe depression.
- SF-36 Physical Component [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]The Health Assessment Questionnaire Short Form 36 (SF-36) determines participants' overall quality of life by assessing 1) limitations in physical functioning due to health problems; 2) limitations in usual role because of physical health problems; 3) bodily pain; 4) general health perceptions; 5) vitality; 6) limitations in social functioning because of physical or emotional problems; 7) limitations in usual role due to emotional problems; and 8) general mental health. Scales 1-4 primarily contribute to the physical component summary score (PCS) of the SF-36. Scores on each scale are summed and averaged (range = 0 "worst"-100 "best").
- SF-36 Mental Component [ Time Frame: Baseline and 1, 3, and 6 months post-treatment ]The Health Assessment Questionnaire Short Form 36 (SF-36) determines participants' overall quality of life by assessing 1) limitations in physical functioning due to health problems; 2) limitations in usual role because of physical health problems; 3) bodily pain; 4) general health perceptions; 5) vitality; 6) limitations in social functioning because of physical or emotional problems; 7) limitations in usual role due to emotional problems; and 8) general mental health. Scales 5-8 primarily contribute to the mental component summary score (PCS) of the SF-36. Scores on each scale are summed and averaged (range = 0 "worst"-100 "best").
- Clinician-Administered PTSD Scale (CAPS) [ Time Frame: Baseline and 1 month post-treatment ]Seventeen questions assess the frequency and intensity of PTSD symptoms. Scores range from zero to 136, with a higher score indicating more severe symptoms.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Male
- Vietnam Combat Veteran
- Diagnosis of combat-related PTSD
- Stable psychotropic regimen for a minimum of three months
- Experiences recurrent nightmares
Exclusion Criteria:
- Bipolar disorder, delirium, dementia, amnestic and other cognitive disorders
- Schizophrenia and other psychotic disorders
- Substance abuse or dependence within the last six months
- Untreated medical disorders known to impact sleep
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00108628
| United States, Pennsylvania | |
| Philadelphia VA Medical Center | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Principal Investigator: | Richard J. Ross, MD PhD | Corporal Michael J. Crescenz VA Medical Center |
| Responsible Party: | US Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00108628 |
| Other Study ID Numbers: |
CLIN-018-03S |
| First Posted: | April 18, 2005 Key Record Dates |
| Results First Posted: | February 18, 2015 |
| Last Update Posted: | February 18, 2015 |
| Last Verified: | February 2015 |
|
Imagery Nightmares Post-Traumatic Stress Disorder Psychotherapy |
|
Dyssomnias Parasomnias Stress Disorders, Traumatic Stress Disorders, Post-Traumatic |
Trauma and Stressor Related Disorders Mental Disorders Sleep Wake Disorders Nervous System Diseases |

